glp-1 benefits for weight loss Long-term Success of GLP-1s Hinges on More Than Just a Prescription Benefits of Semaglutide GLP-1 in

Ozempic and Wegovy both contain semaglutide and are manufactured by Novo Nordisk

Wegovy is FDA-approved specifically for weight management at a dose of 2.4 mg weekly, while Ozempic is approved only for type 2 diabetes at lower doses

But McClains lawsuit alleges that the drug manufacturer downplayed the risks

As long as we uphold safety, transparency, and evidence-based practice, there is roomand reasonto apply these therapies thoughtfully, even beyond traditional BMI thresholds

The Bridge has been extended through December 31, 2027 instead

Insurers are putting up roadblocks to help patients: Among those with coverage for weight loss, 90% have a policy requiring prior authorization